Back to FDA Applications sponsored by MERCK

FDA Drug Application 021042 by MERCK

Application Number	021042
Application Type	New Drug Application
Sponsor Applicant	MERCK
Most Recent Label Available Flag
Current Patent Flag
Action Type	Approval
Chemical Type	New molecular entity (NME)
Therapeutic Potential	Priority
Orphan Code

Action Type	Action Date	Document Type	Application Document ID	Sequence Number	Document Title	Document URL	Document Date
AP	5/20/1999	N	1019	000		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/21042ltr.pdf	5/20/1999
AP	5/20/1999	N	1020	000		http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/021042_52_Vioxx.cfm	5/20/1999
AP	5/20/1999	N	1021	000		http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/21042lbl.pdf	5/20/1999
AP	5/20/1999	N	10316	000	FDA Public Health Advisory	http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm106274.htm	9/30/2004
AP	5/20/1999	N	10319	000		http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103420.htm	9/30/2004
AP	2/25/2000	SCS	20475	001		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/021042_S001_VIOXX.pdf	8/4/2008
AP	10/28/1999	SLR	20496	002		http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/021042_S002_VIOXX.pdf	8/4/2008
AP	3/17/2000	SLR
AP	3/7/2000	SCS	20474	004		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/021042_S004_VIOXX.pdf	8/4/2008
AP	8/10/2000	SCM
AP	4/11/2002	SE8	2706	007		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf	4/11/2002
AP	4/11/2002	SE8	2707	007		http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf	4/11/2002
AP	4/11/2002	SE8	2708	007		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.cfm	4/11/2002
AP	4/11/2002	SLR	2709	008		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf	4/11/2002
AP	4/11/2002	SLR	2710	008		http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf	4/11/2002
AP	4/11/2002	SLR	2711	008		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.cfm	4/11/2002
AP	1/10/2001	SCS	2737	009		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf	4/11/2002
AP	1/10/2001	SCS	2738	009		http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf	4/11/2002
AP	1/10/2001	SCS	2739	009		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.cfm	4/11/2002
AP	4/11/2002	SLR	2712	010		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf	4/11/2002
AP	4/11/2002	SLR	2713	010		http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf	4/11/2002
AP	4/11/2002	SLR	2714	010		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.cfm	4/11/2002
AP	6/13/2001	SCS	20456	011		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/021042_S011_VIOXX.pdf	8/4/2008
AP	4/11/2002	SE1	2715	012		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf	4/11/2002
AP	4/11/2002	SE1	2716	012		http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf	4/11/2002
AP	4/11/2002	SE1	2717	012		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.cfm	4/11/2002
AP	4/11/2002	SLR	2718	013		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf	4/11/2002
AP	4/11/2002	SLR	2719	013		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.htm	4/11/2002
AP	4/11/2002	SLR	2720	013		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.cfm	4/11/2002
AP	4/11/2002	SLR	2721	014		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf	4/11/2002
AP	4/11/2002	SLR	2722	014		http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf	4/11/2002
AP	4/11/2002	SLR	2723	014		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.cfm	4/11/2002
AP	4/6/2002	SCM	20418	015		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021042_S015_VIOXX.pdf	8/1/2008
AP	6/25/2002	SCM	20417	016		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021042_S016_VIOXX.pdf	8/1/2008
AP	5/19/2003	SLR	14202	017		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s017_021052_s011_VioxxTOC.cfm	6/1/2006
AP	8/6/2003	SE8	6502	018		http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21042se8-018,21052se8-012_vioxx_lbl.pdf	8/15/2003
AP	8/6/2003	SE8	6525	018		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21042se8-018,21052se8-012ltr.pdf	8/15/2003
AP	6/27/2003	SLR	6061	020		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21052slr014,015,016,21042slr020,021,022ltr.pdf	7/6/2003
AP	6/27/2003	SLR	14204	020		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s020s021s022_021052_s014s015s016_VioxxTOC.cfm	6/1/2006
AP	6/27/2003	SLR	6062	021		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21052slr014,015,016,21042slr020,021,022ltr.pdf	7/6/2003
AP	6/27/2003	SLR	14205	021		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s020s021s022_021052_s014s015s016_VioxxTOC.cfm	6/1/2006
AP	6/27/2003	SLR	6063	022		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21052slr014,015,016,21042slr020,021,022ltr.pdf	7/6/2003
AP	6/27/2003	SLR	14206	022		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s020s021s022_021052_s014s015s016_VioxxTOC.cfm	6/1/2006
AP	12/16/2003	SLR	7285	023		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21042slr023ltr.pdf	12/19/2003
AP	12/16/2003	SLR	14210	023		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s023_VioxxtmTOC.cfm	6/1/2006
AP	12/16/2003	SLR	7287	024		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21052slr017,21042slr024ltr.pdf	12/19/2003
AP	12/16/2003	SLR	14211	024		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s024_021052_s017_VioxxtmTOC.cfm	6/1/2006
AP	8/19/2004	SE5	10025	026		http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021052s026_021042s019lbl.pdf	8/19/2004
AP	8/19/2004	SE5	10043	026		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21052s019,026ltr.pdf	8/25/2004
AP	8/19/2004	SE5	20367	026		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021042_S026_VIOXX.pdf	7/31/2008
AP	9/14/2004	SLR	10215	028		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21042s028,21052s021ltr.pdf	9/16/2004
AP	9/14/2004	SLR	20366	028		http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021042_S028_VIOXX.pdf	7/31/2008
AP	5/9/2016	SLR	45916	033		http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021042Orig1s033,021052Orig1s024ltr.pdf	5/11/2016
AP	5/9/2016	SLR	45984	033		http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021042s033,021052s024lbl.pdf	5/11/2016

Back to FDA Applications sponsored by MERCK